While thirty million Americans battle alcohol-use disorder, the utilization of medications like Disulfiram and Naltrexone remains strikingly low. Medical professionals' lack of awareness contributes to this issue. Meanwhile, new studies on drugs like Ozempic show potential in reducing alcohol cravings, marking a hopeful advancement.